Cost-effective bioprinter and bioink manufacturer CELLINK signed an exclusive distribution agreement with Thermo Fisher Scientific ANZ, one of the world’s biggest distributors of laboratory equipment for Australia and New Zealand. The agreement includes the distribution of all CELLINK’s products and will help CELLINK to reach more customers in the region.
Thermo Fisher Scientific ANZ , a company with more than 300 commercial employees in the region, will designate a team of specialists to meet CELLINK’s customers’ needs and actively market CELLINK products in the region. The first BIO X will be delivered in August. This agreement enables CELLINK to have better customer care in the region as well as reaching more customers.
CELLINK has created one of the world’s first universal Bioinks currently used by many of the world’s most renowned research institutions. A Bioink can be mixed with living cells to print functional human tissues and if future research is successful, eventually, complete human organs in 3D-Bioprinters. CELLINKs universal Bioink show excellent results and can be used in both CELLINKs proprietary 3D Bioprinters as well as in other bioprinters on the market.
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. The company’s premier brands include: Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services.